OCUFLOX

This brand name is authorized in Australia, Canada, Mexico, United States

Active ingredients

The drug OCUFLOX contains one active pharmaceutical ingredient (API):

1 Ofloxacin UNII A4P49JAZ9H - OFLOXACIN

Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. Read about Ofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OCUFLOX Ophthalmic solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AE01		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5567B, 8383F
Country: CA	Health Products and Food Branch	Identifier(s): 02143291
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 587M95
Country: US	FDA, National Drug Code	Identifier(s): 11980-779